Feng Zhou

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Drug Administration

Respiratory Syndrome Coronavirus

Replacement Therapy

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangrui Jiang, Haixia Su, Weijuan Shang, Feng Zhou, Yan Zhang, Wenfeng Zhao, Qiumeng Zhang, Hang Xie, Lei Jiang, Tianqing Nie, Feipu Yang, Muya Xiong, Xiaoxing Huang, Minjun Li, Ping Chen, Shaoping Peng, Geng-Fu Xiao, Hualiang Jiang, Renhong Tang, Lei-Ke Zhang, Jingshan Shen, Yechun Xu
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir. Nature communications 14 (1) (2023)